Results 101 to 110 of about 268,406 (174)

In-silico analysis of myeloid cells across the animal kingdom reveals neutrophil evolution by colony-stimulating factors. [PDF]

Elife, 2020
Pinheiro D, Mawhin MA, Prendecki M, Woollard KJ.   +3 more
europepmc   +1 more source

Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK) [PDF]

Introduction: We report a cost-effectiveness evaluation of granulocyte colony-stimulating factors (G-CSFs) for prevention of febrile neutropenia (FN) following chemotherapy for non-Hodgkin’s lymphoma (NHL) in the United Kingdom (UK).
Akehurst, R., Cooper, K.L., Stevenson, M.D., Whyte, S.   +3 more
core  

Uso clínico de los factores de crecimiento hematopoyético Clinical use of hematopoietic growth factors

Iatreia, 1994
<p class="MsoNormal"><span style="font-size: 10pt; font-family: Arial">Los factores de crecimiento hematopoyético (FCH) son producto de la excitante y prometedora industria de la biología molecular y la Ingeniería gen ética.
José Domingo Torres Hernández
doaj  

Growth factors as treatment for inflammatory bowel disease: A concise review of the evidence toward their potential clinical utility

The Saudi Journal of Gastroenterology, 2009
In the process of inflammation and repair of the intestinal mucosa in inflammatory bowel disease (IBD), there occurs a complex and an unknown interplay of innate and adaptive immune mechanisms.
Barahona-Garrido Josue, Hernandez-Calleros Jorge, Garcia-Juarez Ignacio, Yamamoto-Furusho Jesus   +3 more
doaj  

Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box? [PDF]

Br J Radiol, 2020
Benna M, Guy JB, Bosacki C, Jmour O, Ben Mrad M, Ogorodniitchouk O, Soltani S, Lan M, Daguenet E, Mery B, Sotton S, Magné N, Vallard A.   +12 more
europepmc   +1 more source

Risks of haematological malignancies in patients treated for solid tumours associated with the use of pegylated granulocyte colony-stimulating factors: A single centre study since 2005. [PDF]

Oncol Lett
Vokurka S, Mastný L, Kliment V, Kulhánková J, Dreslerová J, Šamanová T, Fínek J.   +6 more
europepmc   +1 more source

Assessment of Granulocyte-Colony Stimulating Factors Use at a community-based teaching hospital and compliance with National Comprehensive Cancer Network guidelines. [PDF]

J Taibah Univ Med Sci, 2020
Alhifany AA, McAllister MW.
europepmc   +1 more source

Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan. [PDF]

PLoS One
Tseng TH, Chiang SC, Hsu JC, Ko Y.
europepmc   +1 more source

Genomic analysis of the prognostic value of colony-stimulating factors (CSFs) and colony-stimulating factor receptors (CSFRs) across 24 solid cancer types. [PDF]

Ann Transl Med, 2020
Huang X, Hu P, Zhang J.
europepmc   +1 more source

Encapsulated Streptococcus suis impairs optimal neutrophil functions which are not rescued by priming with colony-stimulating factors. [PDF]

PLoS One
Bleuzé M, Lavoie JP, Bédard C, Gottschalk M, Segura M.   +4 more
europepmc   +1 more source